Deleting <i>Gfi1</i> and <i>Gfi1b</i> does not result in a change in lymphoid- or pDC-specific genes in pDCs.

<p>(<b>A</b>) RT-PCR of lymphoid-specific gene expression in <i>ex </i><i>vivo</i> differentiated B220⁺ CD11c⁺ pDCs from <i>Gfi1</i>^<i>f/f</i><i>; Gfi1b</i>^<i>f/f</i><i>; ERCre</i> mice untreated (WT) and treated (KO) with tamoxifen. RNA isolated from primary B (B) or T (T) cells were used as controls. (<b>B</b>) Quantitative RT-PCR of pDC-specific genes in <i>ex </i><i>vivo</i> differentiated B220⁺ CD11c⁺ pDCs from <i>Gfi1</i>^<i>f/f</i><i>; Gfi1b</i>^<i>f/f</i><i>; ERCre</i> mice untreated (WT) and treated (KO) with tamoxifen. Expression values in arbitrary units are normalized to <i>Hprt</i> transcript abundance.